The Combined Heterozygosity of Factor V Leiden and G20210A Prothrombin Gene Mutation in a Patient With Venous Thromboembolism

Venous thromboembolism (VTE) is a chronic illness that includes pulmonary embolism (PE) and deep vein thrombosis (DVT), and many risk factors are associated. Anticoagulation therapy remains the cornerstone of venous thromboembolism management, and the duration of anticoagulation depends on the risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Machado, Marcia, Cunha, Marta, Gonçalves, Filipe, Fernandes, Carlos, Cotter, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559759/
https://www.ncbi.nlm.nih.gov/pubmed/37809238
http://dx.doi.org/10.7759/cureus.44835
_version_ 1785117574627852288
author Machado, Marcia
Cunha, Marta
Gonçalves, Filipe
Fernandes, Carlos
Cotter, Jorge
author_facet Machado, Marcia
Cunha, Marta
Gonçalves, Filipe
Fernandes, Carlos
Cotter, Jorge
author_sort Machado, Marcia
collection PubMed
description Venous thromboembolism (VTE) is a chronic illness that includes pulmonary embolism (PE) and deep vein thrombosis (DVT), and many risk factors are associated. Anticoagulation therapy remains the cornerstone of venous thromboembolism management, and the duration of anticoagulation depends on the risk of venous thromboembolism. We report a case of a female with a combined heterozygosity of factor V Leiden and G20210A prothrombin gene mutation.
format Online
Article
Text
id pubmed-10559759
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-105597592023-10-08 The Combined Heterozygosity of Factor V Leiden and G20210A Prothrombin Gene Mutation in a Patient With Venous Thromboembolism Machado, Marcia Cunha, Marta Gonçalves, Filipe Fernandes, Carlos Cotter, Jorge Cureus Internal Medicine Venous thromboembolism (VTE) is a chronic illness that includes pulmonary embolism (PE) and deep vein thrombosis (DVT), and many risk factors are associated. Anticoagulation therapy remains the cornerstone of venous thromboembolism management, and the duration of anticoagulation depends on the risk of venous thromboembolism. We report a case of a female with a combined heterozygosity of factor V Leiden and G20210A prothrombin gene mutation. Cureus 2023-09-07 /pmc/articles/PMC10559759/ /pubmed/37809238 http://dx.doi.org/10.7759/cureus.44835 Text en Copyright © 2023, Machado et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Machado, Marcia
Cunha, Marta
Gonçalves, Filipe
Fernandes, Carlos
Cotter, Jorge
The Combined Heterozygosity of Factor V Leiden and G20210A Prothrombin Gene Mutation in a Patient With Venous Thromboembolism
title The Combined Heterozygosity of Factor V Leiden and G20210A Prothrombin Gene Mutation in a Patient With Venous Thromboembolism
title_full The Combined Heterozygosity of Factor V Leiden and G20210A Prothrombin Gene Mutation in a Patient With Venous Thromboembolism
title_fullStr The Combined Heterozygosity of Factor V Leiden and G20210A Prothrombin Gene Mutation in a Patient With Venous Thromboembolism
title_full_unstemmed The Combined Heterozygosity of Factor V Leiden and G20210A Prothrombin Gene Mutation in a Patient With Venous Thromboembolism
title_short The Combined Heterozygosity of Factor V Leiden and G20210A Prothrombin Gene Mutation in a Patient With Venous Thromboembolism
title_sort combined heterozygosity of factor v leiden and g20210a prothrombin gene mutation in a patient with venous thromboembolism
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559759/
https://www.ncbi.nlm.nih.gov/pubmed/37809238
http://dx.doi.org/10.7759/cureus.44835
work_keys_str_mv AT machadomarcia thecombinedheterozygosityoffactorvleidenandg20210aprothrombingenemutationinapatientwithvenousthromboembolism
AT cunhamarta thecombinedheterozygosityoffactorvleidenandg20210aprothrombingenemutationinapatientwithvenousthromboembolism
AT goncalvesfilipe thecombinedheterozygosityoffactorvleidenandg20210aprothrombingenemutationinapatientwithvenousthromboembolism
AT fernandescarlos thecombinedheterozygosityoffactorvleidenandg20210aprothrombingenemutationinapatientwithvenousthromboembolism
AT cotterjorge thecombinedheterozygosityoffactorvleidenandg20210aprothrombingenemutationinapatientwithvenousthromboembolism
AT machadomarcia combinedheterozygosityoffactorvleidenandg20210aprothrombingenemutationinapatientwithvenousthromboembolism
AT cunhamarta combinedheterozygosityoffactorvleidenandg20210aprothrombingenemutationinapatientwithvenousthromboembolism
AT goncalvesfilipe combinedheterozygosityoffactorvleidenandg20210aprothrombingenemutationinapatientwithvenousthromboembolism
AT fernandescarlos combinedheterozygosityoffactorvleidenandg20210aprothrombingenemutationinapatientwithvenousthromboembolism
AT cotterjorge combinedheterozygosityoffactorvleidenandg20210aprothrombingenemutationinapatientwithvenousthromboembolism

Ejemplares similares